BACKGROUND: Community Care of North Carolina (CCNC) initiated an innovative medical home program in the 1990 s to improve primary care in Medicaid-insured populations. CCNC has been successful in improving asthma, diabetes, and cardiovascular outcomes but has not been evaluated in the context of cancer care. We explored whether CCNC enrollment was associated with guideline-concordant follow-up care among breast cancer survivors. METHODS: Using state cancer registry records matched to Medicaid claims, we identified women 18 to 64 years old who were diagnosed with stage 0, I, II, or unstaged breast cancer from 2003 to 2007 and tracked their monthly CCNC enrollment. Using published American Society for Clinical Oncology guidelines to define our outcomes, we employed multivariate logistic regressions to examine, as a function of CCNC enrollment, receipt of mammogram and at least 2 physical examinations/history-taking visits within observational windows consistent with the guidelines. RESULTS: Of the 840 women, approximately half were enrolled into the CCNC for some time during the study period. Between 40% and 85% received follow-up mammogram in accordance with guidelines, with significant variation by CCNC status, and 95% of women received at least 2 physical examinations/history-taking visits. In multivariate models, increasing months of CCNC enrollment was significantly positively associated with receipt of follow-up mammogram but not with physical examinations/history-taking visits. CONCLUSIONS: Results suggest that CCNC enrollment is associated with guideline-concordant follow-up care for Medicaid-insured survivors. Given the growing population of cancer survivors and increased emphasis on primary care medical homes, future studies should explore what factors are associated with medical home participation and whether similar findings are observed with extended follow-up.
BACKGROUND: Community Care of North Carolina (CCNC) initiated an innovative medical home program in the 1990 s to improve primary care in Medicaid-insured populations. CCNC has been successful in improving asthma, diabetes, and cardiovascular outcomes but has not been evaluated in the context of cancer care. We explored whether CCNC enrollment was associated with guideline-concordant follow-up care among breast cancer survivors. METHODS: Using state cancer registry records matched to Medicaid claims, we identified women 18 to 64 years old who were diagnosed with stage 0, I, II, or unstaged breast cancer from 2003 to 2007 and tracked their monthly CCNC enrollment. Using published American Society for Clinical Oncology guidelines to define our outcomes, we employed multivariate logistic regressions to examine, as a function of CCNC enrollment, receipt of mammogram and at least 2 physical examinations/history-taking visits within observational windows consistent with the guidelines. RESULTS: Of the 840 women, approximately half were enrolled into the CCNC for some time during the study period. Between 40% and 85% received follow-up mammogram in accordance with guidelines, with significant variation by CCNC status, and 95% of women received at least 2 physical examinations/history-taking visits. In multivariate models, increasing months of CCNC enrollment was significantly positively associated with receipt of follow-up mammogram but not with physical examinations/history-taking visits. CONCLUSIONS: Results suggest that CCNC enrollment is associated with guideline-concordant follow-up care for Medicaid-insured survivors. Given the growing population of cancer survivors and increased emphasis on primary care medical homes, future studies should explore what factors are associated with medical home participation and whether similar findings are observed with extended follow-up.
Authors: Richard J Bleicher; Karen Ruth; Elin R Sigurdson; Eric Ross; Yu-Ning Wong; Sameer A Patel; Marcia Boraas; Neal S Topham; Brian L Egleston Journal: J Clin Oncol Date: 2012-11-19 Impact factor: 44.544
Authors: Aimee Kendall Roundtree; Sharon H Giordano; Andrea Price; Maria E Suarez-Almazor Journal: Support Care Cancer Date: 2010-12-09 Impact factor: 3.603
Authors: Ahsan M Arozullah; Elizabeth A Calhoun; Michael Wolf; Denise K Finley; Karen A Fitzner; Elizabeth A Heckinger; Nicolle S Gorby; Glen T Schumock; Charles L Bennett Journal: J Support Oncol Date: 2004 May-Jun
Authors: Erin J Aiello Bowles; Leah Tuzzio; Cheryl J Wiese; Beth Kirlin; Sarah M Greene; Steven B Clauser; Edward H Wagner Journal: Cancer Date: 2008-02-15 Impact factor: 6.860
Authors: Stephanie B Wheeler; William R Carpenter; Jeffrey Peppercorn; Anna P Schenck; Morris Weinberger; Andrea K Biddle Journal: Breast Cancer Res Treat Date: 2011-08-13 Impact factor: 4.872
Authors: Lexie R Grove; William J Olesiuk; Alan R Ellis; Jesse C Lichstein; C Annette DuBard; Joel F Farley; Carlos T Jackson; Christopher A Beadles; Joseph P Morrissey; Marisa Elena Domino Journal: Gen Hosp Psychiatry Date: 2017-03-07 Impact factor: 3.238
Authors: Stephanie Brooke Wheeler; Racquel Elizabeth Kohler; Katherine Elizabeth Reeder-Hayes; Ravi K Goyal; Kristen Hassmiller Lich; Alexis Moore; Timothy W Smith; Cathy L Melvin; Hyman Bernard Muss Journal: J Cancer Surviv Date: 2014-05-28 Impact factor: 4.442
Authors: Anne-Marie Meyer; Andrew F Olshan; Laura Green; Adrian Meyer; Stephanie B Wheeler; Ethan Basch; William R Carpenter Journal: N C Med J Date: 2014 Jul-Aug
Authors: Ravi K Goyal; Spiros Tzivelekis; Kenneth J Rothman; Sean D Candrilli; James A Kaye Journal: Support Care Cancer Date: 2017-09-18 Impact factor: 3.603
Authors: Racquel E Kohler; Ravi K Goyal; Kristen Hassmiller Lich; Marisa Elena Domino; Stephanie B Wheeler Journal: Cancer Date: 2015-08-19 Impact factor: 6.860
Authors: Carissa van den Berk-Clark; Emily Doucette; Fred Rottnek; William Manard; Mayra Aragon Prada; Rachel Hughes; Tyler Lawrence; F David Schneider Journal: Health Serv Res Date: 2017-07-03 Impact factor: 3.402
Authors: Lisa P Spees; Stephanie B Wheeler; Xi Zhou; Krutika B Amin; Christopher D Baggett; Jennifer L Lund; Benjamin Y Urick; Joel F Farley; Katherine E Reeder-Hayes; Justin G Trogdon Journal: Cancer Date: 2020-08-11 Impact factor: 6.860
Authors: Pragati Advani; Shailesh Advani; Pratibha Nayak; Helena M VonVille; Pamela Diamond; Jason Burnett; Abenaa M Brewster; Sally W Vernon Journal: J Cancer Surviv Date: 2021-05-13 Impact factor: 4.442